Perspectives on biomarker testing and its influence on outcomes in patients with thyroid cancer

30/11/2021 17 min Episodio 42
Perspectives on biomarker testing and its influence on outcomes in patients with thyroid cancer

Listen "Perspectives on biomarker testing and its influence on outcomes in patients with thyroid cancer"

Episode Synopsis

touchMDT for touchONCOLOLOGY
Listen to key experts from a multidisciplinary team explore the use of biomarkers in thyroid cancer care and how personalized medicine influences patient outcomes
The multidisciplinary team 
Pathologist: Dr Peter Sadow, USA
Endocrinologist: Dr Antonio Matrone, Italy
Oncologist: Dr Lori Wirth, USA

This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Eli Lilly and Bayer. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/personalized-approach-to-treatment-thyroid-cancer-biomarkers-and-targeted-therapies//

More episodes of the podcast touchPODCAST